Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 6 | BMC Cancer

Figure 6

From: Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

Figure 6

Hazard rate estimates for mortality in 1615 ERP tumours and 427 ERN tumours from patients undergoing conservative surgery (quadrantectomy or tumourectomy) plus RT. The mortality risk patterns reveal differences between ERP and ERN tumours in the clinical course of the disease during the critical period spanning from clinical recurrence to death. Vertical lines represent point-wise confidence interval for the model estimated hazards, according to standard asymptotic theory.

Back to article page